Crossmark

Genome Editing: A Tool For Research and Therapy: Targeted genome editing hits the clinic

Crossref DOI link: https://doi.org/10.1038/nm.3721

Published Online: 2014-10-08

Published Print: 2014-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lombardo, Angelo

Naldini, Luigi
License Information

Text and Data Mining valid from 2014-10-01
More Information

Article History

First Online: 8 October 2014

Competing interests

: The authors declare that they receive some research funding from Sangamo BioSciences to perform targeted genome editing with ZFNs and that they are inventors on filed patent applications on targeted genome editing.